A 10-year Retrospective Cross-Sectional Study of Severe Cutaneous Adverse Drug Reactions in Thailand: HLA Typing and ELISpot-Assisted Drug

Published: 21 October 2025| Version 1 | DOI: 10.17632/htyt6mnkn6.1
Contributor:
Chanidapa Wongtada

Description

This supplementary file provides additional methodological details and supporting data for the study on severe cutaneous adverse reactions (SCARs) in Thailand. This multi-center, 10-year retrospective study provides a comprehensive analysis of SCAR phenotypes, drug causality, HLA-B allele associations, and the diagnostic performance of the IFN-γ ELISpot assay across a broad patient population.

Files

Institutions

  • Chulalongkorn University Faculty of Medicine
  • King Chulalongkorn Memorial Hospital

Categories

Drug Adverse Reactions, Human Leukocyte Antigen Disease Association, Thailand, Type IV Hypersensitivity, Enzyme-Linked Immunospot Assay

Licence